Renal Denervation Update From the International Sympathetic Nervous System Summit
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Three recent renal denervation studies in both drug-naïve and drug-treated hypertensive patients demonstrated a significant reduction of ambulatory blood pressure compared with respective sham control groups. Improved trial design, selection of relevant patient cohorts, and optimized interventional procedures have likely contributed to these positive findings. However, substantial variability in the blood pressure response to renal denervation can still be observed and remains a challenging and important problem. The International Sympathetic Nervous System Summit was convened to bring together experts in both experimental and clinical medicine to discuss the current evidence base, novel developments in our understanding of neural interplay, procedural aspects, monitoring of technical success, and others. Identification of relevant trends in the field and initiation of tailored and combined experimental and clinical research efforts will help to address remaining questions and provide much-needed evidence to guide clinical use of renal denervation for hypertension treatment and other potential indications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755 · cited 1×
“from 122 studies, reduction of office systolic BP by 10 mm Hg was related to a reduction in cardiovascular events by 20%, overall mortality by 13%, coronary artery disease by 17%, stroke by 27%, and heart failure by 28%, respectively (65).”
BackgroundLaw, M. R., Morris, J. K., & Wald, N. J. (2009) · BMJ · doi:10.1136/bmj.b1665 · Cited by 2,775 · cited 1×
“In another meta-analysis of 147 randomized trials comprising 464,000 patients, a reduction in 10 mm Hg systolic and 5 mm Hg diastolic office BP was related to a decrease of coronary heart disease and stroke events by ~22 and 41%, respectively, depending on the age of the patient (67).”
A Controlled Trial of Renal Denervation for Resistant Hypertension
Bhatt, D. L., Kandzari, D. E., O'Neill, W. W., D'Agostino, R., Flack, J. M., Katzen, B. T., Leon, M. B., Liu, M., Mauri, L., Negoita, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402670 · Cited by 2,186
Krum, H., Schlaich, M., Whitbourn, R., Sobotka, P. A., Sadowski, J., Bartus, K., Kapelak, B., Walton, A., Sievert, H., Thambar, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60566-3 · Cited by 2,108 · cited 2×
“Keywords blood pressure; cardiovascular disease; hypertension; renal denervation; sympathetic nervous system The initial results from the Symplicity HTN-1 (1) and HTN-2 (2) trials moved catheter based renal denervation (RDN) on to center stage in the cardiovascular field.”
BackgroundSelf-citationAzizi, M., Schmieder, R. E., Mahfoud, F., Weber, M. A., Daemen, J., Davies, J., Basile, J., Kirtane, A. J., Wang, Y., Lobo, M. D., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31082-1 · Cited by 740 · cited 3×
“Poor adherence with prescribed medication in general may be considered an expression of patient’s preference, which could potentially be overcome by alternative one-off interventions such as RDN (15,16).”
BackgroundSelf-citationRenal Autoregulation in Health and Disease
Carlström, M., Wilcox, C. S., & Arendshorst, W. J. (2015) · Physiological Reviews · doi:10.1152/physrev.00042.2012 · Cited by 485 · cited 1×
“Additionally, to overcome the strong and confounding influence of autoregulatory mechanisms on traditional measures of renal vascular tone (48,49), novel means of renal sympathetic vascular control are under investigation for intraprocedural feedback (48,50,51).”
BackgroundTranslational medicine: the antihypertensive effect of renal denervation
DiBona, G. F., & Esler, M. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00647.2009 · Cited by 432 · cited 2×
“RDN increases renal sodium and water excretion by suppressing sympathetically mediated renin secretion and/or renal tubular sodium reabsorption (22).”
BackgroundSelf-citationAnatomic Assessment of Sympathetic Peri-Arterial Renal Nerves in Man
Sakakura, K., Ladich, E., Cheng, Q., Otsuka, F., Yahagi, K., Fowler, D. R., Kolodgie, F. D., Virmani, R., & Joner, M. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.059 · Cited by 406
Tomaszewski, M., White, C., Patel, P., Masca, N., Damani, R., Hepworth, J., Samani, N. J., Gupta, P., Madira, W., Stanley, A., et al. (2014) · Heart · doi:10.1136/heartjnl-2013-305063 · Cited by 404
Renal Afferent Denervation Prevents Hypertension in Rats With Chronic Renal Failure
Campese, V. M., & Kogosov, E. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.878 · Cited by 356 · cited 1×
“However, it is likely that some other pathways contribute to the trans synaptic degeneration (28), because the ganglion cells of renal afferent nerves situated in thoracic and lumbar spine dorsal root ganglia also link to the posterior and lateral hypothalamic nuclei and the locus coeruleus (35,36).”
Background
Cited by
Function of Renal Nerves in Kidney Physiology and Pathophysiology
Osborn, J. W., Tyshynsky, R., & Vulchanova, L. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031620-091656 · Cited by 171
Self-citationBiffi, A., Dell’Oro, R., Quarti-Trevano, F., Cuspidi, C., Corrao, G., Mancia, G., & Grassi, G. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.20503 · Cited by 50
Self-citationAsirvatham-Jeyaraj, N., Gauthier, M. M., Banek, C. T., Ramesh, A., Garver, H., Fink, G. D., & Osborn, J. W. (2021) · Hypertension · doi:10.1161/hypertensionaha.119.14069 · Cited by 24
Self-citationRenal and hypothalamic inflammation in renovascular hypertension: role of afferent renal nerves
Lauar, M. R., Evans, L. C., Van Helden, D., Fink, G. D., Banek, C. T., Menani, J. V., & Osborn, J. W. (2023) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00072.2023 · Cited by 23
Self-citationPeriglomerular afferent innervation of the mouse renal cortex
Tyshynsky, R., Sensarma, S., Riedl, M., Bukowy, J., Schramm, L. P., Vulchanova, L., & Osborn, J. W. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.974197 · Cited by 21
“Catheter-based renal nerve ablation (CBRNA) is an emerging therapy for treatment-resistant hypertension (Kiuchi et al., 2019).”
BackgroundSelf-citation
Metadata
- Authors
- Kiuchi, M. G., Esler, M. D., Fink, G. D., Osborn, J. W., Banek, C. T., Böhm, M., Denton, K. M., DiBona, G. F., Everett, T. H., Grassi, G., Katholi, R. E., Knuepfer, M. M., Kopp, U. C., Lefer, D. J., Lohmeier, T. E., May, C. N., Mahfoud, F., Paton, J. F. R., Schmieder, R. E., Pellegrino, P. R., Sharabi, Y., & Schlaich, M. P.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 73
- Issue
- 23
- Pages
- 3006-3017
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2953135705
- Cited by
- 101
- References
- 17
- FWCI
- 7.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Renal Denervation Update From the International Sympathetic Nervous System Summit. https://app.cochat.ai/papers/10.1016/j.jacc.2019.04.015
- The paper
- Kiuchi, M. G., Esler, M. D., Fink, G. D., Osborn, J. W., Banek, C. T., Böhm, M., Denton, K. M., DiBona, G. F., Everett, T. H., Grassi, G., Katholi, R. E., Knuepfer, M. M., Kopp, U. C., Lefer, D. J., Lohmeier, T. E., May, C. N., Mahfoud, F., Paton, J. F. R., Schmieder, R. E., . . . Schlaich, M. P. (2019). Renal Denervation Update From the International Sympathetic Nervous System Summit. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2019.04.015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.